Back to search results
NCT05260268

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

Active, Not Recruiting
NAAges 18+InterventionalSupportive care
University of Pennsylvania
~361 participants
Updated 2026-07-15 on ClinicalTrials.gov
What's tested:TEST Intervention

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
24 Hour Recall
Measured over 18 Months

Conditions

Liver Transplant; Complications
Cirrhosis
End Stage Liver DIsease
Medication Adherence

Explore related trials

CirrhosisEnd Stage Liver DiseaseLiver Transplantation

Where it's being run

3 sites across 3 states
Florida1
Illinois1
Pennsylvania1

Study leadership

  • Marina Serper, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years or older
Within 3 months of liver transplant
English or Spanish-speaking
Home-dwelling\*
Patient or care partner owns a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone.
\*The definition of "home" includes hotel or short-term housing. Patients who are going to a rehabilitation or skilled nursing facility (SNF) immediately after transplant may still be recruited if the site-PI/Co-I determines they are likely to be discharged to home within 3 months post-transplant.
18 years or older
English or Spanish speaking
Care partner has access to a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone.

Exclusion

Liver transplant recipient who speaks neither English nor Spanish
Any severe uncorrectable vision, hearing, or cognitive impairments that may impede study interviews
Care partner who speaks neither English nor Spanish

What this trial measures

  • 24 Hour Recall18 Months

    Patient self-report of how many pills and how often each medicine was taken over the last 24 hours. Patients will also be asked about the medical indication for each drug. Correct dosing will be measured as a yes/no per drug, having properly shown dose (number of pills), spacing (hours between doses), frequency (times per day), and total pills/day.